Articles with "ezh2" as a keyword



Photo from wikipedia

Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1

Sign Up to like & get
recommendations!
Published in 2023 at "FEBS Open Bio"

DOI: 10.1002/2211-5463.13579

Abstract: The most common type of kidney cancer in adults is renal cell carcinoma (RCC), which accounts for approximately 90% of cases. RCC is a variant disease with numerous subtypes; the most common subtype is clear… read more here.

Keywords: cell carcinoma; cell; renal cell; ezh2 ... See more keywords
Photo from wikipedia

LncRNA UCA1 Antagonizes Arsenic‐Induced Cell Cycle Arrest through Destabilizing EZH2 and Facilitating NFATc2 Expression

Sign Up to like & get
recommendations!
Published in 2020 at "Advanced Science"

DOI: 10.1002/advs.201903630

Abstract: Abstract Arsenic (As) is a widespread metalloid contaminant, and its internal exposure is demonstrated to cause serious detrimental health problems. Albeit considerable studies are performed to interrogate the molecular mechanisms responsible for As‐induced toxicities, the… read more here.

Keywords: cycle arrest; induced cell; cell cycle; ezh2 ... See more keywords
Photo by nci from unsplash

DUAL INHIBITION OF EZH2 AND HDAC IS SYNERGISTIC IN EZH2 DYSREGULATED LYMPHOMAS

Sign Up to like & get
recommendations!
Published in 2017 at "Hematological Oncology"

DOI: 10.1002/hon.2438_120

Abstract: rubicin, epirubicin, vinblastine, etoposide, paclitaxel, and topotecan. RTI‐79's PK characteristics are similar to rifabutin and exhibited no overt toxicity in mice at high doses. RTI‐79 did not exacerbate the known cardiotoxicity associated with doxorubicin as… read more here.

Keywords: rti; ezh2 hdac; dual inhibition; ezh2 ... See more keywords
Photo from wikipedia

Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway

Sign Up to like & get
recommendations!
Published in 2020 at "Gastric Cancer"

DOI: 10.1007/s10120-020-01097-x

Abstract: Background Gastric cancer (GC) is a leading cause of cancer-related mortality worldwide, because of the low efficacy of current therapeutic strategies. Estrogen-related receptor γ (ERRγ) was previously showed as a suppressor of GC. However, the… read more here.

Keywords: gastric cancer; ezh2; signaling pathway; expression ... See more keywords
Photo from wikipedia

Inhibition of Histone Methyltransferase EZH2 Suppresses Endometriotic Vesicle Development in a Rat Model of Endometriosis

Sign Up to like & get
recommendations!
Published in 2020 at "Reproductive Sciences"

DOI: 10.1007/s43032-020-00257-9

Abstract: Endometriosis is a painful gynecological disease with no cure and limited therapeutic options. It has been hypothesized that epigenetic drugs can be used as a nonhormonal treatment for endometriosis. This study was conducted to study… read more here.

Keywords: endometriosis; histone methyltransferase; treatment; inhibition ... See more keywords
Photo by robbie36 from unsplash

Design, synthesis, and antitumor activity of PLGA nanoparticles incorporating a discovered benzimidazole derivative as EZH2 inhibitor.

Sign Up to like & get
recommendations!
Published in 2021 at "Chemico-biological interactions"

DOI: 10.1016/j.cbi.2021.109530

Abstract: PURPOSE Targeting enhancer of zeste homolog 2 (EZH2) can represent a hopeful strategy for oncotherapy. Also, the use of PLGA-based nanoparticles as a novel and rate-controlling carrier system was of our concern. METHODS Benzimidazole derivatives… read more here.

Keywords: plga nanoparticles; activity; ezh2; antitumor activity ... See more keywords
Photo from wikipedia

CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE.

Sign Up to like & get
recommendations!
Published in 2020 at "Trends in immunology"

DOI: 10.1016/j.it.2020.01.008

Abstract: To keep autoreactive T cells under control in SLE patients, immunosuppressive regimens are used, which can increase susceptibility to bacterial and viral infections. Recently, Katsuyama et al., demonstrated that the CD38/NAD/Sirtuin1/EZH2 axis reduces cytolytic CD8+… read more here.

Keywords: histone methyltransferase; ezh2; modulating histone; methyltransferase ezh2 ... See more keywords
Photo from wikipedia

EZH2 inhibition promotes ANGPTL4/CREB1 to suppress the progression of ulcerative colitis.

Sign Up to like & get
recommendations!
Published in 2020 at "Life sciences"

DOI: 10.1016/j.lfs.2020.117553

Abstract: AIMS Enhancer of zeste homolog 2 (EZH2) is associated with ulcerative colitis development. However, the mechanism of EZH2 in ulcerative colitis progression remains unclear. MAIN METHODS Lipopolysaccharide (LPS)-treated Caco-2 cells and dextran sodium sulfate (DSS)-treated… read more here.

Keywords: inhibition; ezh2; ulcerative colitis; creb1 ... See more keywords
Photo from wikipedia

Long noncoding RNA XIST increases the aggressiveness of laryngeal squamous cell carcinoma by regulating miR-124-3p/EZH2.

Sign Up to like & get
recommendations!
Published in 2019 at "Experimental cell research"

DOI: 10.1016/j.yexcr.2019.04.034

Abstract: The long non-coding RNAs (lncRNAs) are an emerging class of cancer regulators. The objective of the study was to elucidate the roles and underlying mechanisms of XIST in laryngeal squamous cell carcinoma. Quantitative real-time PCR… read more here.

Keywords: xist; squamous cell; ezh2; mir 124 ... See more keywords

LncRNA embryonic stem cells expressed 1 (Lncenc1) is identified as a novel regulator in neuropathic pain by interacting with EZH2 and downregulating the expression of BAI1 in mouse microglia.

Sign Up to like & get
recommendations!
Published in 2020 at "Experimental cell research"

DOI: 10.1016/j.yexcr.2020.112435

Abstract: LncRNA embryonic stem cells expressed 1 (Lncenc1), named after its high expression in naïve embryonic stem cells (nESCs), has been rarely studied in almost all pathological processes. Evidences suggest that Lncenc1 is likely to work… read more here.

Keywords: bai1; lncenc1; ezh2; expression ... See more keywords
Photo by edhoradic from unsplash

Design and Synthesis of Dual EZH2/BRD4 Inhibitors to Target Solid Tumors.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.1c01876

Abstract: EZH2 inhibitors that prevent trimethylation of histone lysine 27 (H3K27) are often limited to the treatment of a subset of hematological malignancies. In most solid tumors, EZH2 inhibitors induce reciprocal H3K27 acetylation that subsequently results… read more here.

Keywords: design synthesis; ezh2; ezh2 brd4; brd4 inhibitors ... See more keywords